[The U.S. 2026 Healthcare Cliff: When The Business Model Is The Real Risk](https://wbbsec.com/opinions-and-features/the-u-s-2026-healthcare-cliff-when-the-business-model-is-the-real-risk/)
[The U.S. 2026 Healthcare Cliff: When The Business Model Is The Real Risk](https://wbbsec.com/opinions-and-features/the-u-s-2026-healthcare-cliff-when-the-business-model-is-the-real-risk/)

With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug Companies

By:Posted: Apr 22nd, 2014In: Opinions & Features

4.22.2014 | Forbes

By Steve Brozak

Yesterday in a move that returned attention to healthcare takeovers, Bill Ackman, CEO of the hedge fund Pershing Square Capital, announced a bold and unusual move by partnering with pharmaceutical company, Valeant Pharmaceuticals International, Inc. to acquire a major stake in another biotech.  In this case it is Allergan, Inc., the makers of the injectable wrinkle-remover BOTOX, and several ophthalmic treatments.

For the full article, please click here.

Recent Posts